Company research / STXS

Stereotaxis, Inc. (STXS)

CIK 0001289340 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Stereotaxis, Inc. reported revenue of $32.38M. Revenue grew 20.3% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $30.07M.

Key ratios (year ended 2025-12-31)

52.7%
Gross margin
-68.3%
Operating margin
-66.8%
Net margin
-160.5%
Return on year-end equity
20.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2026-08-12

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$30.07M$32.38M$26.92M$26.77M$28.15M$35.02M$26.63M$28.90M$29.35M$31.14M$32.16M
Cost of Revenue$13.36M$15.31M$12.32M$11.91M$9.68M$11.79M$7.66M$6.14M$5.72M$10.75M$7.53M
Gross Profit$16.71M$17.07M$14.59M$14.86M$18.47M$23.23M$18.97M$22.77M$23.63M$20.39M$24.63M
R&D Expense$10.04M$9.38M$9.76M$10.27M$10.56M$10.20M$8.14M$9.02M$8.22M$6.70M$5.49M
Operating Income-$22.75M-$22.11M-$24.74M-$21.84M-$18.78M-$12.89M-$6.71M-$4.83M-$2.46M-$5.92M-$6.43M
Net Income-$22.32M-$21.64M-$24.05M-$20.71M-$18.29M-$10.72M-$6.65M-$4.59M$116.8K-$5.89M-$5.29M
EPS (Diluted)n/a-$0.25-$0.30-$0.27-$0.26-$0.16-$0.11-$0.10-$0.03-$0.32-$0.54
Total Assets$55.58M$52.25M$46.72M$41.91M$53.41M$60.98M$55.46M$43.58M$18.51M$10.67M$20.97M
Total Liabilities$38.10M$33.53M$35.29M$19.99M$21.48M$21.56M$15.23M$15.06M$11.24M$31.27M$36.50M
Shareholders' Equity$12.24M$13.48M$6.08M$16.34M$26.35M$33.84M$34.62M$22.77M$1.31M-$26.57M-$21.49M
Cash & Equivalents$10.49M$13.42M$12.22M$19.82M$8.59M$38.74M$43.94M$30.18M$10.80M$3.69M$8.50M
Operating Cash Flow-$15.29M-$13.69M-$8.50M-$9.14M-$8.41M-$2.95M-$3.51M-$4.62M-$2.55M-$4.67M-$6.56M
Capital Expenditures$213.0K$93.0K$34.0K$366.0K$2.38M$1.40M$70.9K$29.5K$265.5K$81.6K$410.2K
Free Cash Flow-$15.50M-$13.78M-$8.53M-$9.51M-$10.79M-$4.34M-$3.58M-$4.65M-$2.81M-$4.76M-$6.97M
Dividends Paid$0$0$0$0$0$0$0n/an/a$0$0
Weighted Average Diluted Sharesn/a90.96M85.18M80.70M76.06M75.56M72.75M63.05M52.08M22.61M21.81M
EPS (Basic)n/a-$0.25-$0.30-$0.27-$0.26-$0.16-$0.11-$0.10-$0.03-$0.32-$0.54

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView